| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 杨松 | 天风证券 | 医药生物 | 41.01% | 43.32% | 27.95% | -45.36% | 19 | -72.65% | 2025-07-31 |
| 2 | 杨松 | 天风证券 | 医药生物 | 41.01% | 39.62% | 30.54% | -45.36% | 19 | -72.65% | 2025-08-14 |
| 3 | 仰佳佳 | 申万宏源 | 医药生物 | 40.99% | 38.89% | 31.61% | 16.67% | 1 | -37.64% | 2025-06-26 |
| 4 | 万鹏辉 | 国海证券 | 医药生物 | 40.97% | 40.84% | 27.43% | 100.00% | 5 | 0.00% | 2025-07-28 |
| 5 | 周豫 | 太平洋 | 医药生物 | 40.93% | 46.36% | 30.63% | 20.00% | 23 | -55.62% | 2025-07-28 |
| 6 | 李安飞 | 广发证券 | 医药生物 | 40.84% | 33.43% | 19.81% | 2.86% | 1 | -56.96% | 2025-05-26 |
| 7 | 王斌 | 首创证券 | 医药生物 | 40.79% | 44.57% | 26.05% | -3.03% | 19 | -54.62% | 2025-07-31 |
| 8 | 华挺 | 财通证券 | 医药生物 | 40.79% | 40.79% | 18.71% | -6.67% | 7 | -50.33% | 2025-07-23 |
| 9 | 张林晚 | 上海证券 | 医药生物 | 40.71% | 40.58% | 29.04% | -100.00% | 1 | -18.93% | 2025-07-29 |
| 10 | 唐寅灏 | 中信证券 | 医药生物 | 40.71% | 37.72% | 22.84% | 60.00% | 12 | -8.47% | 2025-06-19 |
| 11 | 王道 | 申万宏源 | 医药生物 | 40.71% | 17.02% | 43.48% | -11.11% | 4 | -42.73% | 2025-08-04 |
| 12 | 王斌 | 首创证券 | 医药生物 | 40.69% | 22.30% | 25.96% | -3.03% | 19 | -54.62% | 2025-08-04 |
| 13 | 阳景 | 浦银国际证券 | 医药生物 | 40.67% | 42.72% | 19.69% | 100.00% | 3 | 0.00% | 2025-07-16 |
| 14 | 王班 | 民生证券 | 医药生物 | 40.64% | 39.59% | 28.93% | -21.43% | 15 | -61.25% | 2025-08-13 |
| 15 | 仰佳佳 | 申万宏源 | 医药生物 | 40.61% | 43.14% | 32.62% | 16.67% | 1 | -37.64% | 2025-06-24 |
| 16 | 王斌 | 首创证券 | 医药生物 | 40.57% | 44.35% | 26.00% | -3.03% | 19 | -54.62% | 2025-07-29 |
| 17 | 叶思奥 | 光大证券 | 医药生物 | 40.55% | 43.44% | 48.85% | -60.00% | 3 | -47.18% | 2025-07-31 |
| 18 | 王班 | 民生证券 | 医药生物 | 40.53% | 43.91% | 31.25% | -21.43% | 15 | -61.25% | 2025-07-31 |
| 19 | 张林晚 | 上海证券 | 医药生物 | 40.33% | 40.20% | 32.66% | -100.00% | 1 | -18.93% | 2025-07-31 |
| 20 | 李安飞 | 广发证券 | 医药生物 | 40.32% | 27.18% | 36.72% | 2.86% | 1 | -56.96% | 2025-05-13 |